The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/20552223

Download in:

View as

General Info

PMID
20552223